AD-associated risk genes, including APP, PICALM, and RBFOX1, were positively correlated with plasma cells, activated CD4+ T cells, and Tregs, linking amyloid-related pathways to adaptive immune activation. This evidence concerns the gene RBFOX1 and Alzheimer disease.